HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients

Summary

This study will be conducted as a single-center, prospective, open-label, randomized trial that will evaluate adult patients admitted with septic shock to the medical critical care unit (MCC). The objective of the study is to determine if the use of hydrocortisone plus fludrocortisone is associated with a faster resolution of shock (defined as 24 hours vasopressor free) when compared to the use of hydrocortisone alone in medical, critically ill septic shock patients.

Timeline

Start

2018-11-05

Primary completion

2019-09-27

Completion

2019-09-27

Drugs

Indications